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The ethanloic extracts of the polyherbal medicinal plants (Asteracantha longifolia, Cyperus rotundus 
and Bryophyllum pinnatum) were evaluated for hepatoprotective activity in carbon tetrachloride 
induced liver damage in rats. The ethanolic extract of polyherbal formulation at 250 mg/kg b.w. 
exhibited a significant protective effect by lowering serum and liver activities of aspartate transaminase 
(AST), alanine transaminase (ALT), acid phosphatase (ACP), alkaline phosphatase (ALP), lactate 
dehydrogenase(LDH), serum bilirubin, serum cholesterol and serum total protein when compared with 
standard silymarin. The hepatoprotective activity of the extracts may be attributed to increased 
regeneration of hepatocytes and inhibitory effects on microsomal enzymes. 
 





Liver, the largest organ in vertebrate body, plays a major 
role in metabolic activities like detoxification and excretion 
of many exogenous and endogenous compounds. Liver 
injury caused by toxic chemicals and certain drugs, has 
been recognized as a toxicological problem. In the absence 
of reliable liver protective drugs in modern system of 
allopathic medical practice, herbal drugs are playing 
important roles in health care programmes world wide 
and there is a resurgence of interest in herbal treatment 
of various hepatic ailments (Shivkumar et al., 2006). 
Survey conducted in tribal areas of Maruthamalai hills, 
Coimbatore, Tamilnadu revealed the uses of these plants 
in treatment of jaundice and various kidney diseases. 
Apart from the tribal uses of these plants in treatment of 
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Abbreviations: AST, Aspartate transaminase; ALT, alanine 
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has been undertaken to evaluate the hepatoprotective 
activities of the plants. Hence attempt was made to assess 
these plants for hepatoprotective activity against CCl4 
induced hepatotoxicity in rats. 
 
 
MATERIALS AND METHODS 
 
Collection of the plant materials 
 
The plant materials used for the polyherbal formulation (PHF) 
preparation were Asteracantha longifolia Nees., Cyperus rotundus 
Linn. and Bryophyllum pinnatum Kurz. The plants were collected 
from Vallaiyar, Rajapalayam and Salem district of Tamilnadu, India 
respectively. They were identified and authenticated by Taxonomist 
Dr. V. Balasubramanian of Department of Botany, Kongunadu Arts 
and Science College, Coimbatore, Tamilnadu, India. Voucher 
specimens were deposited at the herbarium collection of the 
department of Botany. 
 
 
Extraction and preparation of polyherbal formulation 
 
The plant parts were washed, shade dried and powdered. In order 
to prepare the polyherbal formulation, about 75 g (50%) of A. 
longifolia,  45 g (30%) of C.rotundus and 30 g (20%) of B. pinnatum 
plant powders were soaked overnight in 750 ml of 95% ethanol. 




Table 1. Composition of plant parts used for the preparation of polyherbal formulation (PHF). 
 
S/N Name of the Plant Plant part used Composition (%) 
1 Asteracantha longifolia Nees. Whole plant 50% 
2 Cyprus rotundus Linn. Bulbs 30% 




Table 2. Experimental design. 
 
Group Experimental design 
I Control rats- received normal pelleted diet 
II 
Toxic rats-  carbon tetrachloride was induced (1.0ml/ kg b.w.) as single dose with 1:1 volume/ volume 
of liquid paraffin by intraperitoneal  administration for two consecutive days
 
(Manna et al., 2006) 
III Standard drug treated rats – Silymarin ( 25mg / kg / b.w.) by oral administration for 30 days 
IV Polyherbal formulation (PHF) treated rats– (250 mg / kg b.w.) by oral administration for 30 days  
V 
Protective group - normal rats received polyherbal formulation extract (250 mg / kg b. w.) by oral 




This suspension was filtered and the residue was resuspended in 
an equal volume of 95% ethanol for 48 h and filtered again. The two 
filtrates were pooled and the solvent were evaporated in a rotary 
evaporator, to get a yield of 22 g. This extract was dissolved in 
distilled water and this was administered orally to the rats. The 
percentage composition of the plant parts used for the ethanolic 
extract of polyherbal formulation preparation is shown in Table 1.  
 
 
Selection of animals 
 
Healthy adult male wistar albino rats weighing about 150 to 200 g 
were procured from the animal breeding centre, Kerala Agricultural 
University, Mannuthy, Thrissur, Kerala, India. The animals were 
housed in spacious cages. The animals were maintained for 12 h in 
light and dark cycle at 28 ± 2°C in a well ventilated animal house 
under natural conditions in large polypropylene cages and they 
were acclimatized to laboratory conditions for 10 days prior to the 
commencement of the experiment. The animals were fed with 
standard pelleted diet supplied by AVM foods, Coimbatore, 
Tamilnadu, India and provided with water ad libitum. All animal 
experiments were performed according to the ethical guidelines 
suggested by the Institutional animal ethics committee (IAEC).  
 
 
Experimental induction of hepatotoxicity 
 
Hepatic damage was induced in experimental rats by intra-
peritoneal administration of carbon tetrachloride at dose of 1.0 ml 




Experimental design of animals 
 
The rats were divided into five groups of six animals each as given 
in Table 2. 
 
 
Collection of serum sample 
 
After the experimental regimen, the animals were sacrificed by cervical 
decapitation under mild ether anesthesia. Blood was collected and 
centrifuged for 10 min at 2500 rpm. The serum was collected and 
then diluted in the ratio of 1:10 with saline. Aliquot of the diluted 




Collection of liver samples  
 
Liver was removed immediately and washed with ice cold saline. 
10% tissue homogenate was prepared by 0.1M tris HCl homo-
genizing buffer at pH 7.5. The homogenate was used for the assay 









Estimation of biochemical parameters 
 
The serum and liver tissue homogenate was used to assayed the 
marker enzymes and serum constituents like aspartate trans-
aminase (AST), alanine transaminase (ALT), acid phos-phatase 
(ACP), alkaline phosphatase (ALP), lactate dehydrogenase (LDH), 
bilirubin, total protein and cholesterol according to the method of 
Reitman and Frankel (1957), King (1965), King and Armstrong 
(1934), Malloy and Evelyn (1998), Lowry et al. (1951) and Parekh 





Values were represented as the mean of six values ± S.D. The 
results were statistically analyzed using the statistical package, 
MINITAB, version 14. One way analysis of variance was employed 
for comparison among the six groups followed by Fisher’s test. 





From Tables 3 and 4 as well as Figures  1,  2  and 3,  the















I 79.21±0.93 34.76±1.05 66.03±0.73 84.96±0.75 
II 170.64±1.02a* 149.45±2.36a* 183.25±1.04a* 166.79±0.64a* 




















Values are expressed as mean ± SD of six animals. Statistical comparisons: a, Group II and I; b, Group III 
and II; c, Group IV and II; d, Group V and I; e, Group IV and III; * P < 0.05; ns; not significant; 
#
, µ moles of 
phenol liberated/L; 
$




Table 4. Effect of PHF on LDH, in liver of control and 















Values are expressed as mean ± SD of six animals. 
Statistical comparisons are as in Table 3.  
#





activities of marker enzymes AST, ALT, ACP, ALP, LDH 
were significantly increased (p <0.05) in serum and liver 
of CCl4 induced hepatic damaged rats. After the treat-
ment with polyherbal formulation, the values showed near 
normal range in Group IV rats in serum and liver. The 
standard drug silymarin treated group (Group III) also 
showed normal activities. The Group V rats, which were 
treated with polyherbal formulation alone, showed protec-
tive effect without any side effect.  
Figure 4 and Table 5 represent the levels of serum 
bilirubin, serum total protein and serum cholesterol. Levels 
of bilirubin and cholesterol were significantly (p <0.05) 
increased in Group II while the total protein level was 
significantly decreased. This reduction in biochemical 
parameters by ethanolic extract of polyherbal formulation 
(Group IV) was similar when compared to that of 





The liver is an important metabolic organ involved in the 
synthesis of large number of metabolites. It contains 
large amount of marker enzymes (Singh et al., 2005). 
Hepatocellular necrosis leads to very high level of AST 
and ALT in blood released from liver to blood. However, 
alanine transaminase is a better index of injury, as its 
activity represents 90% of total enzymes present in the 
body. The decrease in serum transaminase concentration 
in indicates the stabilization of plasma membrane and 
protection of hepatocytes against the damaged caused 
by carbon tetrachloride (Chandrashekar et al., 2004). 
ALP activity on the other hand is related to the 
functioning of hepatocytes and increase in its activity is 
due to its increased synthesis in the presence of 
increased pressure (Manjunatha et al., 2005). Acid phos-
phatase is a marker enzyme use to assess lysosomal 
changes in vivo as it is localized almost exclusively in 
particles and its release parallel to that of lysosomal 
hydrolyases (Emmanuel et al., 2001). 
Bilirubin, an endogenous organic anion binds reversibly 
to albumin and it is transported to the liver, and then 
conjucated with glucoronic acid and excreted in the bile. 
Hepatobilary disease is indicated when conjugated 
fraction of bilirubin exceeds the upper limit of normal, 
even if the total serum bilirubin is normal or near normal 
(Raghavendren et al., 2004). 
The decline in total protein content can be deemed as a 
useful index of the severity of cellular dysfunction in 
chronic liver disease. The lower level of total protein 
recorted in the serum of CCl4 treated rats reveals the 
severity of hepatopathy. The attainment of near normalcy 
in total protein content of serum of polyherbal treated rats 
conforms the hepatoprotective effect of the selected 
herbs (Venukumar and Latha, 2002) 
Carbon tetrachloride is one of the most commonly used 
hepatoprotection. It is well documented that carbon 
tetrachloride is biotransformed underthe action of 
cytochrome p450 in the microsomal compartment of the 
liver to trichlomethyl radicals which readily reacts with 
molecular oxygen to form trichloromethyl peroxy radicals 
(Raucy et al., 1993). Both radicals can bind covalently to 
the macromolecules and induce peroxidative of the 
membrane lipids of endoplasmic rediculum rich in 
polyunsaturated fatty acids. This leads to the formation of 
lipid peroxides followed by pathological changes such  as 




































































































Figure 2. Effect of PHF on ACP and ALP levels in liver of control and experimental rats. 



























































depression of protein synthesis (Mondal et al., 2005).  
In conclusion, our findings clearly state that polyherbal 
formulation (PHF) extract, with its potent hepatoprotectant, 
seems to be a highly promising agent in protecting 
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Table 5. Effect of PHF on total protein and cholesterol in 
serum of control and experimental rats. 
 
Groups Protein (mg/dl) Cholesterol (mg/dl) 
I 6.06±0.24 95.62±1.10 
II 3.38±0.12a* 148.55±2.19a* 












Values are expressed as mean ± SD of six animals. Statistical 
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